Phone: +86-18018237128        E-mail:  customerservice@eastfine.net
You are here: Home » Blog » Top 10 CAS No. 749927-69-3 Manufacturers of Pharmaceutical Intermediate in 2025

Top 10 CAS No. 749927-69-3 Manufacturers of Pharmaceutical Intermediate in 2025

Views: 0     Author: Site Editor     Publish Time: 2025-07-31      Origin: Site

Understanding CAS No. 749927-69-3 – A Critical Intermediate in Dolutegravir Synthesis

CAS No. 749927-69-3, chemically named (4R,12aS)-7-Hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-9-yl 2,2-dimethylpropanoate, is a highly specialized intermediate used in the synthesis of Dolutegravir, a second-generation integrase strand transfer inhibitor (INSTI) widely used in the treatment of HIV/AIDS.

Dolutegravir is one of the most recommended antiretroviral therapies (ARTs) worldwide, and this intermediate plays a central role in ensuring the final API’s quality, purity, and potency.


Importance of CAS No. 749927-69-3 in Pharmaceutical Manufacturing

Key Intermediate for Dolutegravir Production

Central to the synthesis of Dolutegravir sodium, one of the WHO’s preferred HIV drugs.

Complex Stereochemistry

Requires tight control of stereoisomers, impacting pharmacological performance.

Stringent Regulatory Standards

Produced under cGMP, with full analytical validation for regulated markets.

Widespread Global Use in Fixed-Dose Combinations

Present in branded and generic treatments like TLD (Tenofovir/Lamivudine/Dolutegravir).

Used by NGOs and Public Health Agencies

Essential for large-scale HIV programs in low- and middle-income countries.


Top 10 Manufacturers of CAS No. 749927-69-3

1. Farmhispania Group

  • Location: Barcelona, Spain

  • Overview: Leading supplier of HIV drug intermediates for regulated markets, known for Dolutegravir-related compounds.

  • Specialty: Advanced process chemistry and EU-GMP compliance.

2. Sai Life Sciences

  • Location: Hyderabad, India

  • Overview: End-to-end CDMO experienced in integrase inhibitor intermediates, offering full route development and scale-up.

  • Specialty: Focused on HIV, oncology, and anti-infective synthesis.

3. Eastfine

  • Location: Changzhou City, Jiangsu Province, China

  • Overview: Trusted supplier of Dolutegravir intermediates including CAS 749927-69-3. Offers global export services with regulatory support.

  • Specialty: High-quality, cost-effective manufacturing for antiviral intermediates.

4. Curia Global (formerly AMRI)

  • Location: Albany, New York, USA

  • Overview: Contract manufacturer with experience in complex heterocyclic intermediates used in antiretroviral APIs.

  • Specialty: Route innovation and GMP-certified production.

5. Olon S.p.A.

  • Location: Milan, Italy

  • Overview: Produces Dolutegravir-related intermediates in high-containment environments with FDA/EU certification.

  • Specialty: High-complexity synthesis for regulated markets.

6. Cipla Ltd.

  • Location: Mumbai, India

  • Overview: Key global player in HIV drug manufacturing, producing Dolutegravir APIs and intermediates.

  • Specialty: WHO-prequalified supply chain for global access programs.

7. Delmar Chemicals

  • Location: Montreal, Canada

  • Overview: Offers North American GMP manufacturing of Dolutegravir intermediates with a strong track record in HIV compounds.

  • Specialty: Batch flexibility and regulatory documentation support.

8. Neuland Laboratories

  • Location: Hyderabad, India

  • Overview: Produces Dolutegravir and related intermediates with full cGMP and regulatory documentation.

  • Specialty: Integrated R&D and scalable production.

9. Aarti Pharmalabs

  • Location: Maharashtra, India

  • Overview: Supplier of antiretroviral intermediates to global generic companies.

  • Specialty: Competitive pricing with strict QC systems.

10. Sterling Pharma Solutions

  • Location: Newcastle, UK

  • Overview: Custom manufacturer of complex pharmaceutical intermediates, including antiviral scaffolds.

  • Specialty: High-potency and chiral chemistry capabilities.


Trends in the Pharmaceutical Intermediates Market

Rising Global HIV Treatment Demand

With WHO-backed regimens recommending Dolutegravir, intermediates like CAS 749927-69-3 are in high demand.

Increased Licensing for Generic Dolutegravir

More manufacturers are entering the market under voluntary licenses, increasing intermediate sourcing.

Sustainability and Process Optimization

Manufacturers are adopting greener routes and improving yield efficiencies for better cost and environmental performance.

Regulatory Stringency

High scrutiny on Dolutegravir intermediates demands full traceability and validated analytical methods.

Integrated Supply Chains

Companies are moving toward backward integration of intermediates to stabilize API pricing and supply.


Conclusion

CAS No. 749927-69-3 is a critical intermediate in the synthesis of Dolutegravir, a cornerstone in global HIV treatment strategies. Top manufacturers like Eastfine, Farmhispania, Sai Life Sciences, and Curia ensure consistent and compliant supply, meeting the needs of both commercial pharmaceutical firms and public health initiatives.

As the fight against HIV continues, the role of high-quality intermediate suppliers will remain central to affordable, accessible, and scalable treatments worldwide.


Related Blogs

Contact us
Address: No. 2188, Longcheng Avenue, Zhonglou District, Changzhou City, Jiangsu Province, China 
Phone: +86-18018237128 

Products

Application

About Us

© COPYRIGHT 2024 EASTFINE CO., LTD. ALL RIGHTS RESERVED.